Breast Cysts and Lesions following Estrogen Replacement Therapy in the DES-Exposed
Perinatal Exposure to DES Increases the Susceptibility to Develop Mammary Gland Lesions After Estrogen Replacement Therapy
Estrogens and postcoital contraception
DES prescribed despite known teratogenic and potentially carcinogenic effects
Third generation offspring – granddaughters and grandsons
In opposition to developmental epigenetics transgenerational epigenetics implies an absence of resetting of epigenetic states between generations
Diethylstilboestrol – A long-term legacy
Transgenerational effect of DES, i.e., children of sons or daughters of DES mothers, may have an epigenetic basis
Ovral touted as morning-after pill
Both doctors and patients are wary of DES because of public concern about teratogenesis
Estrogen Use in Children and Adolescents: A Survey
Pediatrics, VOLUME 62 / ISSUE 6, December 1978
Reproductive and hormone-related outcomes in DES third generation women
2018 report from the US National Cancer Institute DES Third Generation Study
Delayed adverse effects of contraceptives
DES used as an emergency contraception, Hungary, 1978
Breast cancer risk for women exposed in utero and their offspring
Diethylstilbestrol: Potential health risks for women exposed in utero and their offspring
Postcoital contraceptives in clinical practice
DES used as an emergency contraception, Czechoslovakia, 1977